Published in Hepatology on November 25, 2014
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev (2015) 1.03
PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells. Sci Rep (2015) 0.87
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Nucleic Acids Res (2015) 0.81
Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair. Mol Cancer (2015) 0.78
Splicing-factor alterations in cancers. RNA (2016) 0.78
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. Mol Cancer (2017) 0.75
Alternative RNA Splicing in the Pathogenesis of Liver Disease. Front Endocrinol (Lausanne) (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology (2006) 9.34
The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol (2007) 6.16
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology (2008) 5.53
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev (2010) 4.75
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology (2007) 4.73
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35
Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci U S A (2006) 3.32
The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J (1997) 2.43
Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol (1994) 2.18
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol (2012) 2.08
Translational strategies for cancer prevention in liver. Nat Rev Cancer (2003) 1.97
An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91
The emerging role of splicing factors in cancer. EMBO Rep (2008) 1.83
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell (2008) 1.70
Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol (1999) 1.67
Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res (2002) 1.64
Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma (2013) 1.53
Alternative splicing and tumor progression. Curr Genomics (2008) 1.43
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci (2010) 1.40
Regulated expression and RNA processing of transcripts from the Srp20 splicing factor gene during the cell cycle. Mol Cell Biol (1997) 1.22
SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Mol Cell Biol (2008) 1.20
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors. Cancer Res (2013) 1.17
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene (2010) 1.11
EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J (2010) 1.11
SR proteins induce alternative exon skipping through their activities on the flanking constitutive exons. Mol Cell Biol (2010) 1.07
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene (2012) 1.06
Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma. J Pathol (2003) 1.00
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function. Nat Commun (2013) 0.96
Regulation of SRp20 exon 4 splicing. Biochim Biophys Acta (2000) 0.92
Global splicing pattern reversion during somatic cell reprogramming. Cell Rep (2013) 0.92
Splicing regulator SLU7 is essential for maintaining liver homeostasis. J Clin Invest (2014) 0.86
Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab (2005) 0.85
Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β. Fibrogenesis Tissue Repair (2012) 0.81
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature (2011) 3.63
Yin Yang 1 is a critical regulator of B-cell development. Genes Dev (2007) 3.06
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity (2007) 2.65
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell (2009) 2.42
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature (2012) 2.36
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol (2002) 2.35
SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat Immunol (2008) 2.29
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol (2009) 2.19
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood (2010) 2.04
Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J (2006) 1.80
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med (2009) 1.80
Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res (2009) 1.65
BCL6 is critical for the development of a diverse primary B cell repertoire. J Exp Med (2010) 1.56
GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells. Mol Endocrinol (2002) 1.53
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest (2009) 1.49
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J Exp Med (2007) 1.47
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J Exp Med (2011) 1.45
Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res (2009) 1.41
Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol Endocrinol (2007) 1.30
Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells. J Biol Chem (2002) 1.30
Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells. J Exp Med (2006) 1.29
Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J Biol Chem (2008) 1.26
Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J Biol Chem (2010) 1.23
SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Mol Cell Biol (2008) 1.20
Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity (2007) 1.17
LAT links the pre-BCR to calcium signaling. Immunity (2003) 1.17
Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity (2008) 1.17
Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. J Biol Chem (2006) 1.14
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood (2011) 1.12
Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells. J Exp Med (2005) 1.12
GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J (2009) 1.12
N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat Immunol (2010) 1.11
Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J Exp Med (2003) 1.10
Transcriptional activation of the ovine follicle-stimulating hormone-beta gene by gonadotropin-releasing hormone involves multiple signal transduction pathways. Endocrinology (2002) 1.09
Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Mol Endocrinol (2007) 1.08
Activin modulates the transcriptional response of LbetaT2 cells to gonadotropin-releasing hormone and alters cellular proliferation. Mol Endocrinol (2006) 1.02
A leucine zipper in the N terminus confers membrane association to SLP-65. Nat Immunol (2005) 0.98
The Ig-alpha ITAM is required for efficient differentiation but not proliferation of pre-B cells. Eur J Immunol (2007) 0.98
Role of PI3K in the generation and survival of B cells. Immunol Rev (2010) 0.97
FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination. J Exp Med (2012) 0.97
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function. Nat Commun (2013) 0.96
The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription. EMBO J (2005) 0.96
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1). Mol Cancer Ther (2014) 0.95
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc Natl Acad Sci U S A (2005) 0.95
Jun N-terminal protein kinase enhances middle ear mucosal proliferation during bacterial otitis media. Infect Immun (2007) 0.94
Different signaling pathways control acute induction versus long-term repression of LHbeta transcription by GnRH. Endocrinology (2002) 0.93
Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia. Blood (2013) 0.92
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood (2012) 0.92
Signaling responses to pulsatile gonadotropin-releasing hormone in LbetaT2 gonadotrope cells. J Biol Chem (2010) 0.92
Gonadotropin-releasing hormone pulse sensitivity of follicle-stimulating hormone-beta gene is mediated by differential expression of positive regulatory activator protein 1 factors and corepressors SKIL and TGIF1. Mol Endocrinol (2011) 0.92
Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL. Blood (2011) 0.92
hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene. PLoS One (2011) 0.89
Methyl scanning: total synthesis of demethylasterriquinone B1 and derivatives for identification of sites of interaction with and isolation of its receptor(s). J Am Chem Soc (2005) 0.89
Neuroprotection by small molecule activators of the nerve growth factor receptor. J Pharmacol Exp Ther (2007) 0.89
Gonadotropin-releasing hormone-desensitized LbetaT2 gonadotrope cells are refractory to acute protein kinase C, cyclic AMP, and calcium-dependent signaling. Endocrinology (2003) 0.89
Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cells. Mol Endocrinol (2011) 0.88
Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media. Infect Immun (2004) 0.88
Self-recognition and clonal selection: autoreactivity drives the generation of B cells. Curr Opin Immunol (2012) 0.88
Identification of a pre-BCR lacking surrogate light chain. J Exp Med (2003) 0.88
Efficient generation of B lymphocytes by recognition of self-antigens. Eur J Immunol (2011) 0.87
Free fatty acids induce Lhb mRNA but suppress Fshb mRNA in pituitary LβT2 gonadotropes and diet-induced obesity reduces FSH levels in male mice and disrupts the proestrous LH/FSH surge in female mice. Endocrinology (2013) 0.86
Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation. Endocrinology (2002) 0.86
The N terminus of the non-T cell activation linker (NTAL) confers inhibitory effects on pre-B cell differentiation. J Immunol (2007) 0.86
Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood (2004) 0.85
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling. Eur J Immunol (2003) 0.85
Identification of novel orally available small molecule insulin mimetics. J Pharmacol Exp Ther (2007) 0.85
Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement. J Immunol (2006) 0.84
Participation of Ras and extracellular regulated kinase in the hyperplastic response of middle-ear mucosa during bacterial otitis media. J Infect Dis (2002) 0.84
PPARG regulates gonadotropin-releasing hormone signaling in LbetaT2 cells in vitro and pituitary gonadotroph function in vivo in mice. Biol Reprod (2010) 0.83
Macrophage activation and Fcgamma receptor-mediated signaling do not require expression of the SLP-76 and SLP-65 adaptors. J Leukoc Biol (2003) 0.83
PLCgamma participates in insulin stimulation of glucose uptake through activation of PKCzeta in brown adipocytes. Exp Cell Res (2002) 0.83
Modulation of gonadotropin-releasing hormone-induced extracellular signal-regulated kinase activation by dual-specificity protein phosphatase 1 in LbetaT2 gonadotropes. Endocrinology (2010) 0.82
Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo. BMC Cancer (2002) 0.81
Constitutively active Gq impairs gonadotropin-releasing hormone-induced intracellular signaling and luteinizing hormone secretion in LbetaT2 cells. Mol Endocrinol (2005) 0.79
Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia. Immunol Res (2006) 0.79
PLC-gamma1 enzyme activity is required for insulin-induced DNA synthesis. Endocrinology (2002) 0.78
Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice. J Immunol (2012) 0.78
The molecular requirements for LAT-mediated differentiation and the role of LAT in limiting pre-B cell expansion. Eur J Immunol (2004) 0.78
Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk. J Immunol (2013) 0.77
Trans-resveratrol inhibits phosphorylation of Smad2/3 and represses FSHβ gene expression by a SirT1-independent pathway in LβT2 gonadotrope cells. Reprod Toxicol (2011) 0.76
Erratum: Responsiveness of B cells is regulated by the hinge region of IgD. Nat Immunol (2015) 0.75
Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature (2016) 0.75
DOCKing innate to adaptive signaling for persistent antibody production. Nat Immunol (2012) 0.75
Quinone replacements for small molecule insulin mimics. Chembiochem (2008) 0.75
Parallel synthesis of indolylquinones and their cell-based insulin mimicry. J Comb Chem (2007) 0.75
PLC-γ1 Enzyme Activity Is Required for Insulin-Induced DNA Synthesis. Endocrinology (2002) 0.75